Mesa Laboratories Inc

Research Mesa Laboratories Inc (MLAB) on Bullrun: valuation model: 48.9% overvalued, market cap USD 549.89M, P/E 82.4, dividend yield 0.6%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerMLAB
ExchangeNASDAQ
CountryUnited States
SectorTechnology
IndustryScientific & Technical Instruments
CurrencyUSD
Valuation signal48.9% overvalued
Market capUSD 549.89M
P/E82.4
Dividend yield0.6%
Financial periodFY2026
RevenueUSD 249.13M
Revenue growth3.4%
Net incomeUSD 6.71M
Free cash flowUSD 39.58M
Gross margin63.5%

Valuation Snapshot

Bullrun's latest valuation model marks Mesa Laboratories Inc as 48.9% overvalued; latest market cap is USD 549.89M; P/E is 82.4; dividend yield is 0.6%.

About Mesa Laboratories Inc

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.

Frequently asked questions

Is Mesa Laboratories Inc overvalued or undervalued?

Bullrun's valuation model currently marks Mesa Laboratories Inc as 48.9% overvalued.

What is Mesa Laboratories Inc's market cap?

Mesa Laboratories Inc's market capitalization is USD 549.89M.

What is Mesa Laboratories Inc's P/E ratio?

Mesa Laboratories Inc's price-to-earnings (P/E) ratio is 82.4.

Does Mesa Laboratories Inc pay a dividend?

Mesa Laboratories Inc has a dividend yield of 0.6%.